Comparison

BMS927711 European Partner

Item no. TMO-T4610-5mg
Manufacturer TargetMol
CASRN 1289023-67-1
Amount 5mg
Category
Type Molecules
Specific against other
Purity 0,991
Citations 1.Luo G, et al. Discovery of (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): an oral calcitonin gene-related peptide (CGRP) a
Smiles Fc1cccc(c1F)[C@@H]6CC[C@@H](OC(=O)N2CCC(CC2)N3c4cccnc4NC3=O)c5ncccc5[C@H]6N
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias CGRP Receptor, BMS 927711 , BMS-927711 , BHV-3000 , BMS927711
Available
Short Description
Rimegepant (BMS 927711) is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.
Shipping
cool pack
Storage
-20°
Target names or alias
BMS 927711 , BMS-927711 , BHV-3000 , BMS927711
Molecular Weight
534, 56
Pathway
Neuroscience|||GPCR/G Protein
Target
CGRP Receptor

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close